Share-Based Compensation Share-Based Compensation (Other Stock-Based Compensation Data) (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
		Dec. 30, 2017		Dec. 31, 2016	Dec. 26, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Phantom Units Granted Under Director Deferral Program, Shares Outstanding		250,000		254,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	[1]	1,481,000	[2]	1,743,000	1,884,000
Weighted-average grant-date fair value of options granted		$ 8.25		$ 6.94	$ 10.80
Total intrinsic value of options exercised (a)	[1]	$ 327,860		$ 290,131	$ 366,188
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	[1]	23,122		18,840	$ 21,837
LiabilityAwards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LiabilityAwardsNonvestedNumber	[3]	33,200	[4]	$ 15,670
LiabilityAwardsNonvestedBalanceSheetFairValue	[3],[4]	$ 32,592
LiabilityAwardsNonvestedRemainingContractualTerm		1 year 8 months 23 days
Equity Instruments Other Than Options
LiabilityAwardsGranted	[3],[5]	$ 19,060
LiabilityAwardsForfeituresExpirations	[3]	(1,530)
LiabilityAwardsExpectedtoVest,Outstanding,Number	[3]	29,590
LiabilityAwardsExpectedtoVest,BalanceSheetFairValue	[3]	$ 29,092
LiabilityAwardsExpectedtoVest,RemainingContractualTerm		1 year 8 months 16 days
Restricted Stock Units (RSUs)
Equity Instruments Other Than Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	[1]	2,824,000		3,054,000	2,759,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value		$ 109.92	[6]	$ 99.06	$ 99.17
Total intrinsic value of converted units	[1]	$ 380,269		$ 359,401	$ 375,510
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	[1]	264,923		257,648	$ 257,831
PEPUnit
Equity Instruments Other Than Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	[1]				300,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 68.94
Total intrinsic value of converted units	[1]	39,782		38,558	$ 37,705
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	[1]	18,833		$ 16,572	$ 22,286
Minimum Award Level [Domain] | PEP_LiabilityAwardsPerformanceBased [Member]
Equity Instruments Other Than Options
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding		0
Maximum | PEP_LiabilityAwardsPerformanceBased [Member]
Equity Instruments Other Than Options
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding		66,400
Target Award Level [Domain] [Domain] | PEP_LiabilityAwardsPerformanceBased [Member]
Equity Instruments Other Than Options
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding		$ 33,200

[1] In thousands

[2] Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.

[3] In thousands.

[4] The outstanding long-term cash awards for which the performance period has not ended as of December 30, 2017, at the threshold, target and maximum award levels were zero, $33.2 million and $66.4 million, respectively.

[5] Grant activity for all long-term cash awards are disclosed at target.

[6] Grant activity for all PSUs are disclosed at target.